A bioequivalence vasoconstriction study comparing two clobetasol propionate 0.5 mg/g ointments after skin application in healthy adult human subjects

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504707-87-00

Acronym

CO/BE/06/2022

Enrollment

100

Registered

2023-09-11

Start date

2023-11-20

Completion date

2024-02-12

Last updated

2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

for which the use of topical corticosteroids with very high potency is indicated., Localized, therapy-resistant inflammatory skin diseases

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026